I-Mab Biopharma
IMAB
#9317
Rank
โ‚ฌ57.99 M
Marketcap
0,71ย โ‚ฌ
Share price
-5.65%
Change (1 day)
-57.67%
Change (1 year)

Operating Margin for I-Mab Biopharma (IMAB)

Operating Margin as of April 2025 (TTM): -7,557.27%

According to I-Mab Biopharma's latest financial reports and stock price the company's current Operating Margin is -7,557.27%. At the end of 2023 the company had an Operating Margin of -7,557.28%.

Operating Margin history for I-Mab Biopharma from 2018 to 2020

Operating Margin at the end of each year

Year Operating Margin Change
2023-7,557.28%122.65%
2022-3,394.26%27.98%
2021-2,652.28%-8551.89%
202031.38%-100.65%
2019-4,829.86%567.04%
2018-724.08%-71.4%
2017-2,531.99%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
-8,391.15% 11.03%๐Ÿ‡บ๐Ÿ‡ธ USA
-1.45%-99.98%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.